No correlations were observed between expression levels of RGS2, DLGAP1 or BCHE and between control or AD patient ages, or between ages and growth inhibition by 8 μm Aβ1–42 in individual LCLs (Supplementary Figure 1). This evidence concerns the gene DLGAP1 and Alzheimer disease.